These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


165 related items for PubMed ID: 2568167

  • 1. Role of glutathione and dependent enzymes in anthracycline-resistant HL60/AR cells.
    Lutzky J, Astor MB, Taub RN, Baker MA, Bhalla K, Gervasoni JE, Rosado M, Stewart V, Krishna S, Hindenburg AA.
    Cancer Res; 1989 Aug 01; 49(15):4120-5. PubMed ID: 2568167
    [Abstract] [Full Text] [Related]

  • 2. Mitomycin C sensitivity in human bladder cancer cells: possible role of glutathione and glutathione transferase in resistance.
    Xu BH, Gupta V, Singh SV.
    Arch Biochem Biophys; 1994 Jan 01; 308(1):164-70. PubMed ID: 8311448
    [Abstract] [Full Text] [Related]

  • 3. Glutathione and related enzymes in rat brain tumor cell resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea and nitrogen mustard.
    Evans CG, Bodell WJ, Tokuda K, Doane-Setzer P, Smith MT.
    Cancer Res; 1987 May 15; 47(10):2525-30. PubMed ID: 2882834
    [Abstract] [Full Text] [Related]

  • 4. Overexpression of glutathione S-transferase and elevation of thiol pools in a multidrug-resistant human colon cancer cell line.
    Chao CC, Huang YT, Ma CM, Chou WY, Lin-Chao S.
    Mol Pharmacol; 1992 Jan 15; 41(1):69-75. PubMed ID: 1346333
    [Abstract] [Full Text] [Related]

  • 5. Lack of reversal of daunorubicin resistance in HL60/AR cells by cyclosporin A.
    Gollapudi S, Gupta S.
    Anticancer Res; 1992 Jan 15; 12(6B):2127-32. PubMed ID: 1363515
    [Abstract] [Full Text] [Related]

  • 6. Potentiation of doxorubicin cytotoxicity by buthionine sulfoximine in multidrug-resistant human breast tumor cells.
    Dusre L, Mimnaugh EG, Myers CE, Sinha BK.
    Cancer Res; 1989 Feb 01; 49(3):511-5. PubMed ID: 2535960
    [Abstract] [Full Text] [Related]

  • 7. Influence of glutathione S-transferases on cellular glutathione determination by flow cytometry using monochlorobimane.
    Ublacker GA, Johnson JA, Siegel FL, Mulcahy RT.
    Cancer Res; 1991 Apr 01; 51(7):1783-8. PubMed ID: 2004362
    [Abstract] [Full Text] [Related]

  • 8. Effect of buthionine sulfoximine and ethacrynic acid on cytotoxic activity of mitomycin C analogues BMY 25282 and BMY 25067.
    Xu BH, Singh SV.
    Cancer Res; 1992 Dec 01; 52(23):6666-70. PubMed ID: 1423311
    [Abstract] [Full Text] [Related]

  • 9. Flow cytometric monitoring of glutathione content and anthracycline retention in tumor cells.
    Nair S, Singh SV, Krishan A.
    Cytometry; 1991 Dec 01; 12(4):336-42. PubMed ID: 1648468
    [Abstract] [Full Text] [Related]

  • 10. Differential roles of 3H-1,2-dithiole-3-thione-induced glutathione, glutathione S-transferase and aldose reductase in protecting against 4-hydroxy-2-nonenal toxicity in cultured cardiomyocytes.
    Li Y, Cao Z, Zhu H, Trush MA.
    Arch Biochem Biophys; 2005 Jul 01; 439(1):80-90. PubMed ID: 15946642
    [Abstract] [Full Text] [Related]

  • 11. The role of glutathione in lymphocyte activation. I. Comparison of inhibitory effects of buthionine sulfoximine and 2-cyclohexene-1-one by nuclear size transformation.
    Hamilos DL, Wedner HJ.
    J Immunol; 1985 Oct 01; 135(4):2740-7. PubMed ID: 4031498
    [Abstract] [Full Text] [Related]

  • 12. Combined effects of buthionine sulfoximine and cepharanthine on cytotoxic activity of doxorubicin to multidrug-resistant cells.
    Kisara S, Furusawa S, Murata R, Ogata M, Hikichi N, Takayanagi Y, Sasaki K.
    Oncol Res; 1995 Oct 01; 7(3-4):191-200. PubMed ID: 8555653
    [Abstract] [Full Text] [Related]

  • 13. Glutathione depletion by L-buthionine sulfoximine antagonizes taxol cytotoxicity.
    Liebmann JE, Hahn SM, Cook JA, Lipschultz C, Mitchell JB, Kaufman DC.
    Cancer Res; 1993 May 01; 53(9):2066-70. PubMed ID: 8097674
    [Abstract] [Full Text] [Related]

  • 14. Cyclophosphamide resistance in medulloblastoma.
    Friedman HS, Colvin OM, Kaufmann SH, Ludeman SM, Bullock N, Bigner DD, Griffith OW.
    Cancer Res; 1992 Oct 01; 52(19):5373-8. PubMed ID: 1356617
    [Abstract] [Full Text] [Related]

  • 15. Hepsulfam sensitivity in human breast cancer cell lines: the role of glutathione and glutathione S-transferase in resistance.
    Armstrong DK, Gordon GB, Hilton J, Streeper RT, Colvin OM, Davidson NE.
    Cancer Res; 1992 Mar 15; 52(6):1416-21. PubMed ID: 1540950
    [Abstract] [Full Text] [Related]

  • 16. Sensitivity of human melanoma cells to L-dopa and DL-buthionine (S,R)-sulfoximine.
    Kable EP, Favier D, Parsons PG.
    Cancer Res; 1989 May 01; 49(9):2327-31. PubMed ID: 2706620
    [Abstract] [Full Text] [Related]

  • 17. Glutathione related enzymes in cis-diamminedichloroplatinum (II)-sensitive and-resistant human ovarian carcinoma cells.
    Oguchi H, Kikkawa F, Kojima M, Maeda O, Mizuno K, Suganuma N, Kawai M, Tomoda Y.
    Anticancer Res; 1994 May 01; 14(1A):193-200. PubMed ID: 7909418
    [Abstract] [Full Text] [Related]

  • 18. Effect of doxorubicin on glutathione and glutathione-dependent enzymes in cultured rat heart cells.
    Paranka NS, Dorr RT.
    Anticancer Res; 1994 May 01; 14(5A):2047-52. PubMed ID: 7847848
    [Abstract] [Full Text] [Related]

  • 19. Role of glutathione in the in vitro synergism between 4-hydroperoxy-cyclophosphamide and cisplatin in leukemia cell lines.
    Peters RH, Jollow DJ, Stuart RK.
    Cancer Res; 1991 May 15; 51(10):2536-41. PubMed ID: 2021933
    [Abstract] [Full Text] [Related]

  • 20. Importance of glutathione and associated enzymes in drug response.
    Shen H, Kauvar L, Tew KD.
    Oncol Res; 1997 May 15; 9(6-7):295-302. PubMed ID: 9406235
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.